US's new scramble for Africa is biomedical imperialism
Briefly

US's new scramble for Africa is biomedical imperialism
"The five-year programme was presented as support for HIV/AIDS, tuberculosis, malaria and epidemic preparedness efforts. However, the terms demanded extensive sharing of national health intelligence, including epidemiological surveillance data and pathogen samples, while offering no binding guarantees that Zimbabwe would receive equitable access to medical technologies developed from them."
"Harare called the proposal an unequal exchange, warning that Zimbabwe risked supplying the raw materials for scientific discovery while the resulting benefits could remain concentrated in the United States and global pharmaceutical firms. Critics increasingly describe this pattern as biomedical extractivism: a toxic combination of exploitative research practices and colonial thinking that reinforces Western dominance."
"The draft would require Zambia to contribute roughly $340m in domestic co-financing while granting the United States far-reaching access to national health data and pathogen-sharing arrangements. One controversial provision would allow the agreement to be terminated if Zambia failed to conclude a separate bilateral compact with Washington over minerals such as copper and cobalt."
Multiple African nations have rejected or suspended US health funding agreements due to exploitative terms. Zimbabwe withdrew from a $367 million HIV/AIDS and epidemic preparedness program after objecting to provisions requiring broad American access to health data and pathogen samples without guarantees of equitable benefit-sharing. Zambia faces similar concerns with a proposed $1 billion partnership that demands domestic co-financing and includes provisions linking health cooperation to mineral trade agreements. Kenya's High Court suspended a $2.5 billion agreement over inadequate data protection safeguards. Critics characterize this pattern as biomedical extractivism, combining exploitative research practices with colonial thinking that concentrates benefits in Western institutions and pharmaceutical firms while African nations supply raw materials.
Read at www.aljazeera.com
Unable to calculate read time
[
|
]